Deerfield Management Company »

Enlink Midstream shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Enlink Midstream (ENLC) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Enlink Midstream

Tip: Access up to 7 years of quarterly data

All positions including Enlink Midstream held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlink Midstream by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $130k 11k 12.16

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Enlink Midstream

ALPS Advisors
Goldman Sachs Group
Tortoise Capital Advisors
Chickasaw Capital Management
Jpmorgan Chase & Co
Dimensional Fund Advisors
Mirae Asset Global Investments
Jennison Associates
Aventail Capital Group
Cushing MLP Asset Management
Fractal Investments
Miller/Howard Investments
Hennessy Advisors
Allianz Asset Management
Kayne Anderson Capital Advisors, L.p

View all funds holding Enlink Midstream